BIOCRYST PHARMACEUTICALS INC (BCRX)
US09058V1035 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 157.2M 783.15% | 270.8M 72.26% | 331.412M 22.38% | 457.39M 38.01% | 544.48M 19.04% | 625.78M 14.93% | 726.55M 16.10% | 811.56M 11.70% | 907.88M 11.87% | 992.02M 9.27% | 1.081B 8.97% | |
| EBITDA YoY % growth | -176.92M -1.65% | -146.96M 16.93% | -100.506M 31.61% | 13.331M 113.26% | 65.64M 392.39% | 117.3M 78.70% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -177.7M -1.66% | -148.4M 16.49% | -102.161M 31.16% | 12.623M 112.36% | 76.153M 503.29% | 145.22M 90.70% | 241.22M 66.11% | 314.04M 30.19% | 419.51M 33.58% | 505.05M 20.39% | 613.78M 21.53% | |
| Operating Margin | -113.04% | -54.80% | -30.83% | 2.76% | 13.99% | 23.21% | 33.20% | 38.70% | 46.21% | 50.91% | 56.78% | |
| EPS YoY % growth | -1.03 4.63% | -1.33 -29.13% | -0.99 25.56% | -0.38 61.87% | -0.08 80.09% | 0.29 479.42% | 0.88 208.44% | 1.22 39.13% | 1.68 37.50% | 2.14 27.07% | 2.55 19.39% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.07 73.69% | -0.07 58.00% | -0.03 43.34% | -0.02 75.71% | 0.02 132.30% | -0.04 38.57% | 0.02 157.01% | 0.02 243.97% | 0.03 24.30% |
| Revenue Q2Q % growth | 131.07M 40.33% | 122.04M 31.56% | 132.24M 20.95% | 136.73M 16.78% | 147.74M 12.72% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 1.622M 103.95% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 5.308M 112.44% | 7.156M 149.39% | 15.374M 75.48% | 17.54M 128.03% | 26.955M 407.82% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.07 63.16% | -0.07 | 0.00 | -6.50% |
| Q2 2024 Q2Q % growth | -0.06 75.00% | -0.18 | 0.12 | 66.23% |
| Q1 2024 Q2Q % growth | -0.17 39.29% | -0.22 | 0.05 | 20.98% |
| Q4 2023 Q2Q % growth | -0.28 26.32% | -0.25 | -0.03 | -12.50% |
| Q3 2023 Q2Q % growth | -0.19 17.39% | -0.24 | 0.05 | 20.19% |
| Q2 2023 Q2Q % growth | -0.24 25.00% | -0.23 | -0.01 | -3.06% |
| Q1 2023 Q2Q % growth | -0.28 30.00% | -0.30 | 0.02 | 8.14% |
| Q4 2022 Q2Q % growth | -0.38 -280.00% | -0.17 | -0.21 | -120.09% |
| Q3 2022 Q2Q % growth | -0.23 30.30% | -0.30 | 0.07 | 22.47% |
| Q2 2022 Q2Q % growth | -0.32 -33.33% | -0.35 | 0.03 | 8.62% |
| Q1 2022 Q2Q % growth | -0.40 -11.11% | -0.37 | -0.03 | -7.10% |
| Q4 2021 Q2Q % growth | -0.10 70.59% | -0.31 | 0.21 | 67.82% |
| Q3 2021 Q2Q % growth | -0.33 -26.92% | -0.30 | -0.03 | -9.92% |
| Q2 2021 Q2Q % growth | -0.24 | -0.25 | 0.01 | 2.26% |
| Q1 2021 Q2Q % growth | -0.36 -50.00% | -0.28 | -0.08 | -29.80% |
| Q4 2020 Q2Q % growth | -0.34 -1,600.00% | -0.26 | -0.08 | -32.96% |
| Q3 2020 Q2Q % growth | -0.26 23.53% | -0.26 | 0.00 | 0.16% |
| Q2 2020 Q2Q % growth | -0.24 29.41% | -0.26 | 0.02 | 7.89% |
| Q1 2020 Q2Q % growth | -0.24 14.29% | -0.25 | 0.01 | 3.04% |
| Q4 2019 Q2Q % growth | -0.02 | -0.26 | 0.24 | 92.36% |
| Q3 2019 Q2Q % growth | -0.34 | -0.33 | -0.01 | -4.53% |
| Q2 2019 Q2Q % growth | -0.34 | -0.32 | -0.02 | -7.53% |
| Q1 2019 Q2Q % growth | -0.28 | -0.28 | 0.00 | -0.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 117.085M 34.98% | 114.75M | 2.335M | 2.03% |
| Q2 2024 Q2Q % growth | 109.332M 32.54% | 100.29M | 9.042M | 9.02% |
| Q1 2024 Q2Q % growth | 92.761M 34.87% | 87.317M | 5.444M | 6.23% |
| Q4 2023 Q2Q % growth | 93.401M 17.41% | 91.807M | 1.594M | 1.74% |
| Q3 2023 Q2Q % growth | 86.742M 14.39% | 87.673M | -931K | -1.06% |
| Q2 2023 Q2Q % growth | 82.491M 25.88% | 82.606M | -115K | -0.14% |
| Q1 2023 Q2Q % growth | 68.778M 37.78% | 73.111M | -4.333M | -5.93% |
| Q4 2022 Q2Q % growth | 79.55M 68.68% | 77.149M | 2.401M | 3.11% |
| Q3 2022 Q2Q % growth | 75.83M 85.00% | 76.117M | -287K | -0.38% |
| Q2 2022 Q2Q % growth | 65.53M 31.16% | 65.594M | -64K | -0.10% |
| Q1 2022 Q2Q % growth | 49.92M 161.91% | 52.387M | -2.467M | -4.71% |
| Q4 2021 Q2Q % growth | 47.16M 1,073.13% | 50.53M | -3.37M | -6.67% |
| Q3 2021 Q2Q % growth | 40.99M 571.97% | 40.885M | 105K | 0.26% |
| Q2 2021 Q2Q % growth | 49.96M 1,640.77% | 29.245M | 20.715M | 70.83% |
| Q1 2021 Q2Q % growth | 19.06M 295.44% | 9.067M | 9.993M | 110.21% |
| Q4 2020 Q2Q % growth | 4.02M -89.88% | 15.038M | -11.018M | -73.27% |
| Q3 2020 Q2Q % growth | 6.1M 242.70% | 3.677M | 2.423M | 65.90% |
| Q2 2020 Q2Q % growth | 2.87M 97.93% | 2.301M | 569K | 24.73% |
| Q1 2020 Q2Q % growth | 4.82M -18.17% | 4.376M | 444K | 10.15% |
| Q4 2019 Q2Q % growth | 39.73M | 10.074M | 29.656M | 294.38% |
| Q3 2019 Q2Q % growth | 1.78M | 3.024M | -1.244M | -41.14% |
| Q2 2019 Q2Q % growth | 1.45M | 2.06M | -610K | -29.61% |
| Q1 2019 Q2Q % growth | 5.89M | 3.172M | 2.718M | 85.69% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 41.28% | -0.3% | 0.18% |
| Revenue | 0% | 19.08% | 0% | 3.5% |